Clinical predictors of risk of hypoglycaemia during addition and titration of insulin glargine for type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical predictors of risk of hypoglycaemia during addition and titration of insulin glargine for type 2 diabetes mellitus

Published:2013-02-24 Issue:7 Volume:15 Page:622-628
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Karl D. M.¹,Gill J.²,Zhou R.³,Riddle M. C.⁴

Affiliation:

1. The Endocrine Clinic; Portland; OR; USA

2. Sanofi US; Bridgewater; NJ; USA

3. Department of Biostatistics, Medpace; Cincinnati; OH; USA

4. Division of Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University; Portland; OR; USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12072/fullpdf

Reference25 articles.

1. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003

2. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes;Buse;Diabetes Care,2009

3. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes;Rosenstock;Diabetologia,2008

4. Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled study in patients with type 2 diabetes;Raskin;Diabetes Metab Res Rev,2009

5. A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study;Gerstein;Diabet Med,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data;Diabetes, Obesity and Metabolism;2020-11-17

2. Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self‐titrating insulin glargine U‐100;Diabetes, Obesity and Metabolism;2019-08

3. Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground;Diabetes Care;2019-06-08

4. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries;Advances in Therapy;2019-05-22

5. Sociodemographic and clinical correlates of key outcomes from a Mobile Insulin Titration Intervention (MITI) for medically underserved patients;Patient Education and Counseling;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3